# Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital

> **NCT06601595** · — · NOT_YET_RECRUITING · sponsor: **Mohamed Nasr** · enrollment: 100 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Spondylarthropathies
- TNF-alpha Inhibitors

## Interventions

- **DRUG:** TNF inhibitors
- **DRUG:** conventional ibd medical treatment

## Key facts

- **NCT ID:** NCT06601595
- **Lead sponsor:** Mohamed Nasr
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2026-01
- **Final completion:** 2026-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06601595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06601595, "Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06601595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*